Administering Triamcinolone in Gout Flare Management

Assessment and Treatment Guidelines

The American College of Rheumatology recommends intramuscular triamcinolone acetonide 60 mg as an initial dose, followed by oral prednisone if needed, for patients with gout flare 1
An inadequate response to initial therapy for gout flare is defined as either <20% improvement in pain score within 24 hours or <50% improvement in pain score ≥24 hours after starting treatment, according to the American College of Rheumatology 1
The European League Against Rheumatism recommends prednisolone 30-35 mg daily for 5 days as a fixed dosing regimen for gout flares 2

For patients not responding adequately to initial therapy, guidelines recommend either switching to another monotherapy or adding a second recommended agent, such as colchicine plus NSAIDs or oral corticosteroids plus colchicine 1, 2
Consider combination therapy with colchicine plus NSAIDs, oral corticosteroids plus colchicine, or intra-articular steroids with any other modality for severe gout attacks not responding to initial therapy 1, 2

Repeated corticosteroid administration increases risks of dysphoria and mood disorders, elevated blood glucose, fluid retention, and immunosuppression with increased infection risk, according to the American College of Rheumatology and European League Against Rheumatism 2
Monitor closely for corticosteroid-related adverse effects when considering a second dose of triamcinolone after 24 hours 2

The American College of Rheumatology recommends IM triamcinolone acetonide for acute gout flares when oral medications cannot be used, although the specific details of this recommendation are not provided in the cited text 3

Choose intra-articular injection over IM when treating localized joint disease, as triamcinolone hexacetonide or acetonide injected directly into affected joints provides superior local control with less systemic exposure 3